SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·04/02/2025 12:05:45
Listen to the news
Gainers
- Sunshine Biopharma (NASDAQ:SBFM) shares increased by 59.1% to $3.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $8.9 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 55.48% to $0.33. The company's market cap stands at $6.7 million.
- Processa Pharmaceuticals (NASDAQ:PCSA) stock moved upwards by 26.21% to $0.52. The company's market cap stands at $2.7 million.
- Greenwich LifeSciences (NASDAQ:GLSI) shares rose 17.71% to $10.9. The market value of their outstanding shares is at $143.2 million.
- Enzo Biochem (NYSE:ENZ) shares increased by 17.61% to $0.4. The company's market cap stands at $20.9 million.
- Curis (NASDAQ:CRIS) shares increased by 12.8% to $1.65. The market value of their outstanding shares is at $13.9 million. As per the press release, Q4 earnings came out 2 days ago.
Losers
- Reshape Lifesciences (NASDAQ:RSLS) stock fell 64.7% to $0.56 during Wednesday's pre-market session. The company's market cap stands at $1.8 million.
- Syra Health (NASDAQ:SYRA) stock declined by 46.47% to $0.14. The market value of their outstanding shares is at $1.7 million.
- Edgewise Therapeutics (NASDAQ:EWTX) stock declined by 30.51% to $13.99. The company's market cap stands at $1.3 billion.
- Impact BioMedical (AMEX:IBO) stock decreased by 21.44% to $0.64. The company's market cap stands at $7.4 million.
- Petros Pharma (NASDAQ:PTPI) stock decreased by 19.17% to $0.07. The market value of their outstanding shares is at $1.7 million.
- Pulmonx (NASDAQ:LUNG) stock decreased by 16.89% to $5.71. The market value of their outstanding shares is at $227.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.